CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $364,000 | -41.1% | 33,864 | -17.2% | 0.00% | -77.8% |
Q4 2018 | $618,000 | +0.3% | 40,905 | +22.8% | 0.02% | +63.6% |
Q3 2018 | $616,000 | -24.5% | 33,316 | -6.7% | 0.01% | -26.7% |
Q2 2018 | $816,000 | -0.4% | 35,698 | +24.0% | 0.02% | -21.1% |
Q1 2018 | $819,000 | – | 28,793 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
Clearline Capital LP | 196,583 | $253,592 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |